NCT05155813View on ClinicalTrials.gov

Prevalence of Sleep Apnea and Atrial Fibrillation

UnknownOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Sleep ApneaAtrial Fibrillation

Interventions

DEVICE

WatchPAT

FDA-approved portable home sleep testing device worn on the wrist.

Trial Locations (1)

02215

RECRUITING

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

Itamar-Medical, Israel

All Listed Sponsors

collaborator

Itamar-Medical, Israel

INDUSTRY

lead

Brigham and Women's Hospital

OTHER